Predictive Model for PENS Response in Subacromial Pain Syndrome
Development of a Predictive Model to Identify Clinical Factors Associated With Response to Percutaneous Electrical Nerve Stimulation in Patients With Subacromial Pain Syndrome
1 other identifier
interventional
269
0 countries
N/A
Brief Summary
Subacromial pain syndrome (SPS) is one of the most common causes of shoulder pain, leading to significant disability and socioeconomic burden. Although percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve (SN) has shown positive therapeutic outcomes, individual response to the intervention varies considerably. This study aims to develop a multivariable predictive model to estimate clinical response to SN-targeted PENS in patients with SPS. The model will be built using clinical, psychological, and neural mechanosensitivity variables. The goal is to enhance patient selection and guide personalized treatment strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedStudy Start
First participant enrolled
September 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 10, 2026
July 14, 2025
July 1, 2025
1.1 years
July 3, 2025
July 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity
Pain intensity will be measured with a 100 mm Visual Analogue Scale (VAS), ranging from 0 mm (no pain) to 100 mm (worst imaginable pain). This is the primary outcome used to evaluate the clinical response to a single ultrasound-guided session of percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve in patients with subacromial pain syndrome. This outcome will be used as the dependent variable in the multivariable predictive model.
4 weeks post-intervention
Study Arms (1)
Suprascapular Nerve PENS
EXPERIMENTALParticipants in this arm will receive a single ultrasound-guided session of percutaneous electrical nerve stimulation (PENS) targeting the suprascapular nerve. The procedure involves needle placement adjacent to the suprascapular nerve and electrical stimulation for 30 minutes.
Interventions
Ultrasound-guided percutaneous electrical nerve stimulation applied to the suprascapular nerve using a monophasic or biphasic current at 10 Hz frequency and 250 μs pulse width. Intensity is progressively increased to patient tolerance, aiming to induce visible muscle contractions of the supraspinatus and infraspinatus. Duration of the session is 30 minutes.
Eligibility Criteria
You may qualify if:
- Adults aged between 18 and 65 years.
- Clinical diagnosis of subacromial pain syndrome (SAPS), based on the following clinical criteria:
- Pain localized to the anterolateral shoulder region.
- Symptoms present for more than 6 weeks.
- Painful arc during shoulder abduction.
- Positive Neer or Hawkins-Kennedy impingement signs.
- Positive Jobe (empty can) test or external rotation resistance test.
- Visual Analogue Scale (VAS) for shoulder pain ≥ 3/10 in the previous week.
- Able to understand study procedures and sign informed consent.
You may not qualify if:
- Bilateral shoulder pain.
- History of fracture, dislocation, or surgical intervention on the affected shoulder.
- Presence of other shoulder pathologies such as adhesive capsulitis (frozen shoulder), glenohumeral instability, or full-thickness rotator cuff tear.
- Medical contraindications for PENS application (e.g., active anticoagulation, pregnancy, or decompensated psychiatric condition).
- Diagnosed cervical radiculopathy or myelopathy.
- Neurological or cognitive disorders interfering with study participation.
- Presence of chronic widespread pain syndromes, such as fibromyalgia.
- Belonephobia (severe needle phobia) that prevents intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Néstor Requejo Salinaslead
- University of Alcalacollaborator
- Centro Universitario La Sallecollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator, Department of Physiotherapy, University of Alcalá and Centro Superior Universitario La Salle
Study Record Dates
First Submitted
July 3, 2025
First Posted
July 14, 2025
Study Start
September 20, 2025
Primary Completion (Estimated)
November 10, 2026
Study Completion (Estimated)
November 10, 2026
Last Updated
July 14, 2025
Record last verified: 2025-07